Back to Cancer Australia's website

Cancer Australia

Select a guideline

Recommendations for use of Bisphosphonates


Membership of NBOCC* Bisphosphonates Working Group

This guideline was developed by a multidisciplinary working group convened by NBOCC*.

Dr Nick Pavlakis Medical Oncologist (chair)
Ms Denice Bassanelli Consumer Representative
Ms Sholeh Boyle Specialist Breast Nurse
Dr Rosyln Drummond Radiation Oncologist
Dr Belinda Kiely Medical Oncologist
Ms Marlene Parsons Consumer Representative
Ms Geraldine Robertson Consumer Representative
Associate Professor Andrew Spillane Surgical Oncologist
Dr Bronwyn Stuckey Endocrinologist

NBOCC* acknowledges the NBOCC* Breast Cancer Guidelines Update Steering Committee, chaired by Dr Catherine Shannon, for their input into the development of this guideline.

NBOCC* staff

Ms Sue Sinclair General Manager
Ms Ornella Care Program Manager
Ms Emma Lonsdale Project Officer
Dr Anne Nelson Evidence Review and Research Leader
Ms Rosemary Wade Senior Project Officer - Research

External review

NBOCC* acknowledges those who gave their time to provide comment on the draft guideline recommendations as part of the external review process.

The National Breast Cancer Foundation provided funding for the development and production of this guideline.

Development process

Priority topic areas for NBOCC* guideline development are determined in consultation with key stakeholders including experts in relevant disciplines and consumer representatives. A specific multidisciplinary Working Group, including consumers, is established for each topic identified and is involved in all aspects of guideline development. A systematic evidence review is undertaken for each guideline. All members are asked to declare any conflicts of interest and these declarations are recorded. The content of the guideline is not influenced by any external funding body. The guideline is reviewed externally by key stakeholders and the wider community and endorsement is sought from relevant professional colleges and groups in Australia.

* In July 2011, National Breast and Ovarian Cancer Centre (NBOCC) amalgamated with Cancer Australia to form a single national agency, Cancer Australia, to provide leadership in cancer control and improve outcomes for Australians affected by cancer.

Published using CeCC Docbook Manager